NTC
North Tide Capital Portfolio holdings
AUM
$469M
This Quarter Return
+3.4%
1 Year Return
+6.55%
3 Year Return
+14.78%
5 Year Return
–
10 Year Return
–
AUM
$1.39B
AUM Growth
+$1.39B
(+4.8%)
Cap. Flow
+$67.2M
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
74.96%
Holding
28
New
8
Increased
3
Reduced
4
Closed
6
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$88.7M |
| 2 |
Gilead Sciences
GILD
|
$58.5M |
| 3 |
SVU
SUPERVALU Inc.
SVU
|
$44.5M |
| 4 |
STJ
St Jude Medical
STJ
|
$36.5M |
| 5 |
Quest Diagnostics
DGX
|
$36.3M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$79.9M |
| 2 |
Bausch Health
BHC
|
$49.7M |
| 3 |
GHDX
Genomic Health, Inc.
GHDX
|
$45.8M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$43.4M |
| 5 |
Baxter International
BAX
|
$34.3M |
Sector Composition
| 1 | Healthcare | 83.39% |
| 2 | Consumer Discretionary | 3.6% |
| 3 | Technology | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Select Medical
SEM
$1.61B
| $211M | 15.2% | 13,000,000 -450,000 | -3% | -$7.29M |
|
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $177M | 12.8% | 3,000,000 +1,500,000 | +100% | +$88.7M |
|
|
AMED
3
DELISTED
Amedisys
AMED
| $159M | 11.47% | 4,000,000 | – | – |
|
|
KND
4
DELISTED
Kindred Healthcare
KND
| $101M | 7.32% | 5,000,000 -513,999 | -9% | -$10.4M |
|
|
SVU
5
DELISTED
SUPERVALU Inc.
SVU
| $101M | 7.3% | 12,500,000 +5,500,000 | +79% | +$44.5M |
|
6
Viatris
VTRS
$12.3B
| $67.9M | 4.9% | 1,000,000 | – | – |
|
7
Community Health Systems
CYH
$387M
| $63M | 4.55% | 1,000,000 -500,000 | -33% | -$31.5M |
|
|
8
Gilead Sciences
GILD
$140B
| $58.5M | 4.23% | +500,000 | New | +$58.5M |
|
|
AFAM
9
DELISTED
Almost Family Inc
AFAM
| $49.9M | 3.6% | 1,250,000 | – | – |
|
10
Orthofix Medical
OFIX
$592M
| $49.7M | 3.59% | 1,500,000 -300,000 | -17% | -$9.94M |
|
|
TVTY
11
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $46.1M | 3.33% | 3,850,000 | – | – |
|
|
STJ
12
DELISTED
St Jude Medical
STJ
| $36.5M | 2.64% | +500,000 | New | +$36.5M |
|
|
13
Quest Diagnostics
DGX
$20.3B
| $36.3M | 2.62% | +500,000 | New | +$36.3M |
|
|
MGLN
14
DELISTED
Magellan Health Services, Inc.
MGLN
| $35M | 2.53% | 500,000 | – | – |
|
|
ELOS
15
DELISTED
Syneron Medical Ltd
ELOS
| $31.9M | 2.3% | 3,000,000 | – | – |
|
16
Align Technology
ALGN
$10.3B
| $31.4M | 2.26% | +500,000 | New | +$31.4M |
|
|
IMS
17
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $30.7M | 2.21% | +1,000,000 | New | +$30.7M |
|
18
Labcorp
LH
$23.1B
| $30.3M | 2.19% | +250,000 | New | +$30.3M |
|
|
VVUS
19
DELISTED
Vivus Inc
VVUS
| $29.5M | 2.13% | 12,500,000 | – | – |
|
|
AEGR
20
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $19M | 1.37% | 1,000,000 +700,000 | +233% | +$13.3M |
|
|
NXGN
21
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $16.6M | 1.2% | +1,000,000 | New | +$16.6M |
|
22
Option Care Health
OPCH
$4.65B
| $3.63M | 0.26% | +1,000,000 | New | +$3.63M |
|
|
23
Baxter International
BAX
$12.7B
| – | – | -500,000 | Closed | -$34.3M |
|
|
24
Bausch Health
BHC
$2.74B
| – | – | -250,000 | Closed | -$49.7M |
|
|
25
Boston Scientific
BSX
$156B
| – | – | -4,500,000 | Closed | -$79.9M |
|